This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rodriguez, M. S.
Right arrow Articles by Hay, R. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rodriguez, M. S.
Right arrow Articles by Hay, R. T.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, November 2000, p. 8458-8467, Vol. 20, No. 22
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Multiple C-Terminal Lysine Residues Target p53 for Ubiquitin-Proteasome-Mediated Degradation

Manuel S. Rodriguez,1 Joana M. P. Desterro,1 Sonia Lain,2 David P. Lane,2 and Ronald T. Hay1,*

School of Biology, University of St. Andrews, St. Andrews Fife KY16 9ST,1 and Surgery and Molecular Oncology, University of Dundee, Ninewells Hospital and Medical School, Dundee DD1 9SY,2 Scotland, United Kingdom

Received 13 April 2000/Returned for modification 8 June 2000/Accepted 14 August 2000

In normal cells, p53 is maintained at a low level by ubiquitin-mediated proteolysis, but after genotoxic insult this process is inhibited and p53 levels rise dramatically. Ubiquitination of p53 requires the ubiquitin-activating enzyme Ubc5 as a ubiquitin conjugation enzyme and Mdm2, which acts as a ubiquitin protein ligase. In addition to the N-terminal region, which is required for interaction with Mdm2, the C-terminal domain of p53 modulates the susceptibility of p53 to Mdm2-mediated degradation. To analyze the role of the C-terminal domain in p53 ubiquitination, we have generated p53 molecules containing single and multiple lysine-to-arginine changes between residues 370 and 386. Although wild-type (WT) and mutant molecules show similar subcellular distributions, the mutants display a higher transcriptional activity than WT p53. Simultaneous mutation of lysine residues 370, 372, 373, 381, 382, and 386 to arginine residues (6KR p53 mutant) generates a p53 molecule with potent transcriptional activity that is resistant to Mdm2-induced degradation and is refractory to Mdm2-mediated ubiquitination. In contrast to WT p53, transcriptional activity directed by the 6KR p53 mutant fails to be negatively regulated by Mdm2. Those differences are also manifest in HeLa cells which express the human papillomavirus E6 protein, suggesting that p53 C-terminal lysine residues are also implicated in E6-AP-mediated ubiquitination. These data suggest that p53 C-terminal lysine residues are the main sites of ubiquitin ligation, which target p53 for proteasome-mediated degradation.


* Corresponding author. Mailing address: School of Biology, BMS Building, University of St. Andrews, North Haugh, St. Andrews Fife KY16 9ST, United Kingdom. Phone: 44 1334 463399. Fax: 44 1334 462595. E-mail: rth{at}st-and.ac.uk.


Molecular and Cellular Biology, November 2000, p. 8458-8467, Vol. 20, No. 22
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Joubel, A., Chalkley, R. J., Medzihradszky, K. F., Hondermarck, H., Burlingame, A. L. (2009). Identification of New p53 Acetylation Sites in COS-1 Cells. Mol. Cell. Proteomics 8: 1167-1173 [Abstract] [Full Text]  
  • Kruse, J.-P., Gu, W. (2009). MSL2 Promotes Mdm2-independent Cytoplasmic Localization of p53. J. Biol. Chem. 284: 3250-3263 [Abstract] [Full Text]  
  • Daskalogianni, C., Apcher, S., Candeias, M. M., Naski, N., Calvo, F., Fahraeus, R. (2008). Gly-Ala Repeats Induce Position- and Substrate-specific Regulation of 26 S Proteasome-dependent Partial Processing. J. Biol. Chem. 283: 30090-30100 [Abstract] [Full Text]  
  • Zou, J., Marjanovic, J., Kisseleva, M. V., Wilson, M., Majerus, P. W. (2007). Type I phosphatidylinositol-4,5-bisphosphate 4-phosphatase regulates stress-induced apoptosis. Proc. Natl. Acad. Sci. USA 104: 16834-16839 [Abstract] [Full Text]  
  • Bins, A. D., Wolkers, M. C., van den Boom, M. D., Haanen, J. B. A. G., Schumacher, T. N. M. (2007). In Vivo Antigen Stability Affects DNA Vaccine Immunogenicity. J. Immunol. 179: 2126-2133 [Abstract] [Full Text]  
  • Brooks, C. L., Li, M., Gu, W. (2007). Mechanistic Studies of MDM2-mediated Ubiquitination in p53 Regulation. J. Biol. Chem. 282: 22804-22815 [Abstract] [Full Text]  
  • Giono, L. E., Manfredi, J. J. (2007). Mdm2 Is Required for Inhibition of Cdk2 Activity by p21, Thereby Contributing to p53-Dependent Cell Cycle Arrest. Mol. Cell. Biol. 27: 4166-4178 [Abstract] [Full Text]  
  • Sasaki, T., Gan, E. C., Wakeham, A., Kornbluth, S., Mak, T. W., Okada, H. (2007). HLA-B-associated transcript 3 (Bat3)/Scythe is essential for p300-mediated acetylation of p53. Genes Dev. 21: 848-861 [Abstract] [Full Text]  
  • Abida, W. M., Nikolaev, A., Zhao, W., Zhang, W., Gu, W. (2007). FBXO11 Promotes the Neddylation of p53 and Inhibits Its Transcriptional Activity. J. Biol. Chem. 282: 1797-1804 [Abstract] [Full Text]  
  • Nair, V. D., McNaught, K. St. P., Gonzalez-Maeso, J., Sealfon, S. C., Olanow, C. W. (2006). p53 Mediates Nontranscriptional Cell Death in Dopaminergic Cells in Response to Proteasome Inhibition. J. Biol. Chem. 281: 39550-39560 [Abstract] [Full Text]  
  • Watson, I. R., Blanch, A., Lin, D. C. C., Ohh, M., Irwin, M. S. (2006). Mdm2-mediated NEDD8 Modification of TAp73 Regulates Its Transactivation Function. J. Biol. Chem. 281: 34096-34103 [Abstract] [Full Text]  
  • Chao, C., Wu, Z., Mazur, S. J., Borges, H., Rossi, M., Lin, T., Wang, J. Y. J., Anderson, C. W., Appella, E., Xu, Y. (2006). Acetylation of Mouse p53 at Lysine 317 Negatively Regulates p53 Apoptotic Activities after DNA Damage.. Mol. Cell. Biol. 26: 6859-6869 [Abstract] [Full Text]  
  • Lacroix, M., Toillon, R.-A., Leclercq, G. (2006). p53 and breast cancer, an update.. Endocr Relat Cancer 13: 293-325 [Abstract] [Full Text]  
  • Alshatwi, A. A., Han, C.-T., Schoene, N. W., Lei, K. Y. (2006). Nuclear Accumulations of p53 and Mdm2 Are Accompanied by Reductions in c-Abl and p300 in Zinc-Depleted Human Hepatoblastoma Cells.. Exp. Biol. Med. 231: 611-618 [Abstract] [Full Text]  
  • RILEY, K. J.-L., CASSIDAY, L. A., KUMAR, A., MAHER, L. J. III (2006). Recognition of RNA by the p53 tumor suppressor protein in the yeast three-hybrid system.. RNA 12: 620-630 [Abstract] [Full Text]  
  • Schneider-Merck, T., Pohnke, Y., Kempf, R., Christian, M., Brosens, J. J., Gellersen, B. (2006). Physical Interaction and Mutual Transrepression between CCAAT/Enhancer-binding Protein {beta} and the p53 Tumor Suppressor. J. Biol. Chem. 281: 269-278 [Abstract] [Full Text]  
  • Chan, W. M., Mak, M. C., Fung, T. K., Lau, A., Siu, W. Y., Poon, R. Y.C. (2006). Ubiquitination of p53 at Multiple Sites in the DNA-Binding Domain. Mol Cancer Res 4: 15-25 [Abstract] [Full Text]  
  • Baxter, B. K., Abeliovich, H., Zhang, X., Stirling, A. G., Burlingame, A. L., Goldfarb, D. S. (2005). Atg19p Ubiquitination and the Cytoplasm to Vacuole Trafficking Pathway in Yeast. J. Biol. Chem. 280: 39067-39076 [Abstract] [Full Text]  
  • Perrot, V., Rechler, M. M. (2005). The Coactivator p300 Directly Acetylates the Forkhead Transcription Factor Foxo1 and Stimulates Foxo1-Induced Transcription. Mol. Endocrinol. 19: 2283-2298 [Abstract] [Full Text]  
  • Krummel, K. A., Lee, C. J., Toledo, F., Wahl, G. M. (2005). The C-terminal lysines fine-tune P53 stress responses in a mouse model but are not required for stability control or transactivation. Proc. Natl. Acad. Sci. USA 102: 10188-10193 [Abstract] [Full Text]  
  • Feng, L., Lin, T., Uranishi, H., Gu, W., Xu, Y. (2005). Functional Analysis of the Roles of Posttranslational Modifications at the p53 C Terminus in Regulating p53 Stability and Activity. Mol. Cell. Biol. 25: 5389-5395 [Abstract] [Full Text]  
  • Wiederschain, D., Kawai, H., Shilatifard, A., Yuan, Z.-M. (2005). Multiple Mixed Lineage Leukemia (MLL) Fusion Proteins Suppress p53-mediated Response to DNA Damage. J. Biol. Chem. 280: 24315-24321 [Abstract] [Full Text]  
  • Yagishita, N., Ohneda, K., Amano, T., Yamasaki, S., Sugiura, A., Tsuchimochi, K., Shin, H., Kawahara, K.-i., Ohneda, O., Ohta, T., Tanaka, S., Yamamoto, M., Maruyama, I., Nishioka, K., Fukamizu, A., Nakajima, T. (2005). Essential Role of Synoviolin in Embryogenesis. J. Biol. Chem. 280: 7909-7916 [Abstract] [Full Text]  
  • Michiue, H., Tomizawa, K., Wei, F.-Y., Matsushita, M., Lu, Y.-F., Ichikawa, T., Tamiya, T., Date, I., Matsui, H. (2005). The NH2 Terminus of Influenza Virus Hemagglutinin-2 Subunit Peptides Enhances the Antitumor Potency of Polyarginine-mediated p53 Protein Transduction. J. Biol. Chem. 280: 8285-8289 [Abstract] [Full Text]  
  • Boutell, C., Everett, R. D. (2004). Herpes Simplex Virus Type 1 Infection Induces the Stabilization of p53 in a USP7- and ATM-Independent Manner. J. Virol. 78: 8068-8077 [Abstract] [Full Text]  
  • Poulin, D. L., Kung, A. L., DeCaprio, J. A. (2004). p53 Targets Simian Virus 40 Large T Antigen for Acetylation by CBP. J. Virol. 78: 8245-8253 [Abstract] [Full Text]  
  • Coulombe, P., Rodier, G., Bonneil, E., Thibault, P., Meloche, S. (2004). N-Terminal Ubiquitination of Extracellular Signal-Regulated Kinase 3 and p21 Directs Their Degradation by the Proteasome. Mol. Cell. Biol. 24: 6140-6150 [Abstract] [Full Text]  
  • Yerlikaya, A., Stanley, B. A. (2004). S-Adenosylmethionine Decarboxylase Degradation by the 26 S Proteasome Is Accelerated by Substrate-mediated Transamination. J. Biol. Chem. 279: 12469-12478 [Abstract] [Full Text]  
  • Luo, J., Li, M., Tang, Y., Laszkowska, M., Roeder, R. G., Gu, W. (2004). Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo. Proc. Natl. Acad. Sci. USA 101: 2259-2264 [Abstract] [Full Text]  
  • Li, M., Brooks, C. L., Wu-Baer, F., Chen, D., Baer, R., Gu, W. (2003). Mono- Versus Polyubiquitination: Differential Control of p53 Fate by Mdm2. Science 302: 1972-1975 [Abstract] [Full Text]  
  • Iwakuma, T., Lozano, G. (2003). MDM2, An Introduction. Mol Cancer Res 1: 993-1000 [Abstract] [Full Text]  
  • Meek, D. W., Knippschild, U. (2003). Posttranslational Modification of MDM2. Mol Cancer Res 1: 1017-1026 [Abstract] [Full Text]  
  • Boutell, C., Everett, R. D. (2003). The Herpes Simplex Virus Type 1 (HSV-1) Regulatory Protein ICP0 Interacts with and Ubiquitinates p53. J. Biol. Chem. 278: 36596-36602 [Abstract] [Full Text]  
  • Wang, Y.-H., Tsay, Y.-G., Tan, B. C.-M., Lo, W.-Y., Lee, S.-C. (2003). Identification and Characterization of a Novel p300-mediated p53 Acetylation Site, Lysine 305. J. Biol. Chem. 278: 25568-25576 [Abstract] [Full Text]  
  • Grossman, S. R., Deato, M. E., Brignone, C., Chan, H. M., Kung, A. L., Tagami, H., Nakatani, Y., Livingston, D. M. (2003). Polyubiquitination of p53 by a Ubiquitin Ligase Activity of p300. Science 300: 342-344 [Abstract] [Full Text]  
  • Giandomenico, V., Simonsson, M., Gronroos, E., Ericsson, J. (2003). Coactivator-Dependent Acetylation Stabilizes Members of the SREBP Family of Transcription Factors. Mol. Cell. Biol. 23: 2587-2599 [Abstract] [Full Text]  
  • Li, M., Luo, J., Brooks, C. L., Gu, W. (2002). Acetylation of p53 Inhibits Its Ubiquitination by Mdm2. J. Biol. Chem. 277: 50607-50611 [Abstract] [Full Text]  
  • Takenobu, T., Tomizawa, K., Matsushita, M., Li, S.-T., Moriwaki, A., Lu, Y.-F., Matsui, H. (2002). Development of p53 Protein Transduction Therapy Using Membrane-permeable Peptides and the Application to Oral Cancer Cells. Molecular Cancer Therapeutics 1: 1043-1049 [Abstract] [Full Text]  
  • Blattner, C., Hay, T., Meek, D. W., Lane, D. P. (2002). Hypophosphorylation of Mdm2 Augments p53 Stability. Mol. Cell. Biol. 22: 6170-6182 [Abstract] [Full Text]  
  • Ard, P. G., Chatterjee, C., Kunjibettu, S., Adside, L. R., Gralinski, L. E., McMahon, S. B. (2002). Transcriptional Regulation of the mdm2 Oncogene by p53 Requires TRRAP Acetyltransferase Complexes. Mol. Cell. Biol. 22: 5650-5661 [Abstract] [Full Text]  
  • Lohrum, M. A. E., Woods, D. B., Ludwig, R. L., Balint, E., Vousden, K. H. (2001). C-Terminal Ubiquitination of p53 Contributes to Nuclear Export. Mol. Cell. Biol. 21: 8521-8532 [Abstract] [Full Text]  
  • Gu, J., Nie, L., Wiederschain, D., Yuan, Z.-M. (2001). Identification of p53 Sequence Elements That Are Required for MDM2-Mediated Nuclear Export. Mol. Cell. Biol. 21: 8533-8546 [Abstract] [Full Text]  
  • Bai, L., Merchant, J. L. (2001). ZBP-89 Promotes Growth Arrest through Stabilization of p53. Mol. Cell. Biol. 21: 4670-4683 [Abstract] [Full Text]  
  • Zhang, Y., Xiong, Y. (2001). Control of p53 Ubiquitination and Nuclear Export by MDM2 and ARF. Cell Growth Differ. 12: 175-186 [Abstract] [Full Text]  
  • Lai, Z., Ferry, K. V., Diamond, M. A., Wee, K. E., Kim, Y. B., Ma, J., Yang, T., Benfield, P. A., Copeland, R. A., Auger, K. R. (2001). Human mdm2 Mediates Multiple Mono-ubiquitination of p53 by a Mechanism Requiring Enzyme Isomerization. J. Biol. Chem. 276: 31357-31367 [Abstract] [Full Text]  
  • Mullally, J. E., Moos, P. J., Edes, K., Fitzpatrick, F. A. (2001). Cyclopentenone Prostaglandins of the J Series Inhibit the Ubiquitin Isopeptidase Activity of the Proteasome Pathway. J. Biol. Chem. 276: 30366-30373 [Abstract] [Full Text]  
  • Chernov, M. V., Bean, L. J. H., Lerner, N., Stark, G. R. (2001). Regulation of Ubiquitination and Degradation of p53 in Unstressed Cells through C-terminal Phosphorylation. J. Biol. Chem. 276: 31819-31824 [Abstract] [Full Text]  
  • Kurtzman, A. L., Schechter, N. (2001). Ubc9 interacts with a nuclear localization signal and mediates nuclear localization of the paired-like homeobox protein Vsx-1 independent of SUMO-1 modification. Proc. Natl. Acad. Sci. USA 98: 5602-5607 [Abstract] [Full Text]